Sunil Healthcare

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE671C01016
NSEID:
BSEID: 537253
View on BSE

INR

67.78

0.00 (0.00%)

BSENSE

Feb 10

BSE+NSE Vol: 7

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Phaarmasia

Concord Drugs

Sunil Healthcare

Makers Labs.

Samrat Pharma

Godavari Drugs

Kabra Drugs

Guj. Inject(Ker)

Amwill Health

Asston Pharmaceu

Accretion Pha.

Why is Sunil Healthcare Ltd ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.21%

Poor long term growth as Net Sales has grown by an annual rate of 1.43% over the last 5 years
Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.63 times

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sunil Healthcare for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Sunil Healthcare

-10.76%

-0.20

56.13%

Sensex

9.15%

0.69

11.54%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

1.43%

EBIT Growth (5y)

42.73%

EBIT to Interest (avg)

1.26

Debt to EBITDA (avg)

6.68

Net Debt to Equity (avg)

0.84

Sales to Capital Employed (avg)

0.97

Tax Ratio

17.68%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.10%

ROCE (avg)

4.91%

ROE (avg)

4.97%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.02

EV to EBIT

17.44

EV to EBITDA

9.13

EV to Capital Employed

1.01

EV to Sales

1.42

PEG Ratio

0.09

Dividend Yield

ROCE (Latest)

5.00%

ROE (Latest)

2.55%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bullish

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

PAT(Latest six months)

Higher at Rs 1.59 cr

ROCE(HY)

Highest at 6.69%

DEBT-EQUITY RATIO(HY)

Lowest at 0.88 times

-1What is not working for the Company

CASH AND CASH EQUIVALENTS(HY)

Lowest at Rs 2.59 cr

Loading Valuation Snapshot...

Here's what is working for Sunil Healthcare

Profit After Tax (PAT) - Latest six months

At Rs 1.59 cr has Grown at 245.87%

Year on Year (YoY)

MOJO Watch

PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Latest six months

Higher at Rs 1.59 cr

than preceding 12 month period ended Dec 2025 of Rs 0.18 cr

MOJO Watch

In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Debt-Equity Ratio - Half Yearly

Lowest at 0.88 times

in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Sunil Healthcare

Cash and Cash Equivalents - Half Yearly

Lowest at Rs 2.59 cr

in the last six half yearly periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents